The artery to lasting health 2 3 Medox® is anthocyanins. The size of the anthocyanin molecules makes them able easily to penetrate cell membranes and the "Blood-Brain-Barrier". As a sample, Cyanidin-3β-Glucopyranoside = 484g/mol.
Conclusions:
Our observations suggest that the alterations of PON1 activity by anthocyanin (Medox®) observed in hypercholesterolemic HDL reflect a shift to an improvement in cholesterol efflux capacity of HDL and may provide a link between anthocyanion and cardioprotective effects.
Our results suggest that anthocyanin supplementation (Medox®) in dyslipidemic patients has a beneficial effect on the lipoprotein profile, which include a decrease in LDL-cholesterol and an increase in HDHL-cholesterol concentrations. The beneficial effects may be partially explained by the improvement of cholesterol efflux capacity, a key metric of HDL function, via enhancing HDL-PON1 activity. These findings reinforce the concept that assessment of HDL function rather than HDL level may prove informative in refining our understanding of anthocyanin mediated athero-protection. Effects of anthocyanins on cardiovascular risk factors and inflammation in pre hypertensive men; a double-blind randomized placebo-controlled crossover study. SS Hassellund, A Flaa, SE kjeldsen, Seljeflot, A karlsen I Erlund and R Rostrup Conclusion: The present study strengthens the evidence that anthocyanins (Medox®) may increase HDL-cholesterol levels, and this is demonstrated for the first time in prehypertencive and non-dyslipidemic men. Other beneficial effects, including modulating effects on Chronic Inflammation were not registered in this short trial time.
Published: "The Journal of Human Hypertension", USA, 2013. ___________________________________________________________________________
Anthocyanins protect human endothelial cells from mild hyperoxia damage through modulation of Nrf2 pathway
Francesco Cimino, Antonio Speciale, Sirajudheen Anwar, Raffaela Canali, Elisabeth Ricciardi, Fabio Virgili, Domenico Trommbetta, Antonia Saila Conclusion: This study confirms that dietary anthocyanins (Medox®) and/or their metabolites can protect endothelial cells against mild hyperoxia-induced alterations acting as cell signaling modulators.
In other words:
This study shows that anthocyanins and/or their metabolites, present in human serum after oral administration of a dietary plant-derived supplementation (Medox®), can protect HUVECs against mild hyperoxia-induced alterations acting as cell signaling modulators and inducing activation of the Nrf2/ARE pathway.
Published online: Springer Verlag Berlin Heidelberg Germany 2012
Spray-drier at the manufacturing plant for Medox® Conclusion: Anthocyanin consumption (Medox®) significantly decreased the levels of serum high sensitivity C-reactive protein (hsCRP) (-21,6% vs -2,5% placebo, P=0.001) and plasma IL-1ß( -12,8% vs -1,3% placebo, P= 0.019).
We also found a significant difference in the LDL cholesterol (-10,4% verses -0,3% placebo, P= 0.030, and HDL cholesterol level changes (-14,0% vs -0,9% placebo, P=0.036) between the two groups.
In cell culture assays in vitro, purified anthocyanin mixture of Delphinidin-3-ß-glucoside, and cyanidin-3-ß-glucoside (from Polyphenols/Biolink Group, Norway) inhibited IL-6 and IL-1ßinduced CRP production (P<0.05) in HepG2 cell line and LPS-induced VCAM-1 secretion (P=<0.05) in porcine iliac artery endothelial cell line respectively in a dose-dependent manner.
In other words: The supplementation of anthocyanin mixture (Medox® and Medox® pure single molecules) to hypercholesterolemia subjects for 24 weeks reduced serum levels of CRP, VCAM-1 and IL-1ß, which involved the improvement of the lipid profile, In addition, different anthocyanin compounds (Polyphenols, Norway) were found to have additive or synergistic effects in mediating anti-inflammatory responses in vitro cell culture assays.
Published in: Nutrition, Metabolism & Cardiovascular Diseases, USA, 2012
Years of scientific research in our laboratories is the fundament of Medox®.
Purified Anthocyanin Supplementation Improves Endothelial Function via NO-cGMP Activation in Hypercholesterolemic Individuals
Yanna Zhu,1,2 Min Xia,1,2 Yan Yang,1,2 Fengqiong Liu,1,2 Zhongxia Li,1,2 Yuantao Hao,1,3 Mantian Mi,4 Tianru Jin,1,2,5 and Wenhua Ling1,2* Conclusions: Anthocyanin supplementation improves endothelium-dependent vasodilation in hypercholesterolemic individuals. This effect involves activation of the NO-cGMP signaling pathway, improvements in the serum lipid profile, and decreased inflammation.
In other words: Significant increases of FMD from 8.3% (0.6%) at baseline to 11.0% (0.8%) at 1 h and 10.1% (0.9%) at 2 h were observed after short-term anthocyanin consumption, concomitantly with increases of plasma anthocyanin concentrations (P < 0.05). In the study participants who received long term anthocyanin intervention, compared with the control group, we observed significant increases in the FMD (28.4% vs 2.2%), cGMP (12.6% vs -1.2%), and HDL-cholesterol concentrations, but decreases in the serum soluble vascular adhesion molecule-1 and LDL cholesterol concentrations (P < 0.05).
The changes in the cGMP and HDL cholesterol concentrations positively correlated with FMD in the anthocyanin group (P < 0.05). In the presence of NO-cGMP inhibitors, the effects of anthocyanin on endothelial function were abolished in human participants and in a rat aortic ring model.
We have demonstrated for the first time that dietary anthocyanin supplementation improves endothelium-dependent vasodilation through the activation of the NO-cGMP signaling pathway in hypercholesterolemic individuals. Additional investigations are needed to assess the causative relationship between the beneficial effect of anthocyanins on the lipid profile and the reduction in inflammatory molecule release. 
Supplementation with Cyanidin-3-O-b-Glucoside Protects against Hypercholesterolemia-Mediated Endothelial Dysfunction and Attenuates Atherosclerosis in Apolipoprotein E-Deficient Mice 1-3
Yun Wang,4,5 Yuhua Zhang,4,5 Xiaoming Wang,4,5 Yan Liu,4,5 and Min Xia4,5* 4Guangdong Provincial Key Laboratory of Food, Nutrition and Health, and 5Department of Nutrition, School of Public Health, Sun Yat-sen University (Northern Campus), Guangzhou, Guangdong Province, P.R. China
Conclusion:
Taken together, this study indicates that the mechanism of action of the anthocyanin, C3G, is to ameliorate hypercholes-terolemia-induced endothelial dysfunction and atherosclerosis by reducing cholesterol and 7-oxysterols levels via the ABCG1 pathway, thus decreasing superoxide production and enhancing eNOS activity and NO bioavailability. Published: "The Journal of Nutrition", 142: 1033-1037, USA, 2012
One of the Rotavapors used in an early generation of our patented Medox® manufacturing plant is still in use. Conclusion: Our findings reveal a novel mechanism by which anthocyanin regulates FoxO1mediated transcription of ATGL and thus inhibits adipocyte lipolysis, suggesting its potential therapeutic application in diabetes-associated hyperlipidemia.
Gut Microbiota Metabolism of Anthocyanin Promotes Reverse Cholesterol Transport in Mice Via Repressing miRNA-10b
In other words: Taken together, our results indicated that anthocyanin C3G apparently eliminated the impacts of high-glucose on the induction of adipocytes lipolysis by reducing FoxO1 GlcNAcylation and suppressing gene expression of ATGL. Although it appears hard to get the concentration of anthocyanin shown in this study from daily consumed foods, our findings provide a novel insight into the potential implications of anthocyanin in preventing and/or treating diabetes-associated hyperlipidemia in humans. 
Cyanidin-3-O-ß-glucoside upregulates hepatic cholesterol 7Î±-hydroxylase expression and reduces hypercholesterolemia in mice

Conclusion:
Our results indicate that the hypocholesterolemic activity of cyanidin-3-O-ßglucoside was, at least in part, mediated by activating the potential LXRConclusion: Our results indicate that the hypocholesterolemic activity of cyanidin-3-O-ß-glucoside was, at least in part, mediated by activating the potential LXRɑ-CYP7A1-bile acid excretion pathway, thus contributing to the antiatherogenic effect of cyanidin-3-O-ß-glucoside. Importantly, cyanidin-3-O-ß-glucoside could activate LXRɑ in an agonist-dependent manner.
In other words: The present study has clearly shown that Cy-3-G possesses the antiatherogenic and hypocholesterolemic effects in the ApoE-deficient mouse model. Mechanistically, the hypocholesterolemic effect of Cy-3-G may be through ac-tivating the potential LXRɑ-CYP7A1-bile acid excretion path-way in vivo. More importantly, we demonstrated for the first time that Cy-3-G could activate LXRɑ in an agonist-dependent manner.
Funding: This work was supported by grants from the National Natural Science Foundation of China (30730079) 
Cyanidin-3-O-glucoside counters the response to TNF-alpha of endothelial cells by activating Nrf2 pathway
Conclusion:
Our data confirm the hypothesis that natural Nrf2 and HO-1 inducers, such as C3G and other dietary phytochemicals, might be a potential therapeutic strategy to protect vascular system against various stressors preventing several pathological conditions.
In other words:
Our results strongly support the hypothesis that C3G, as well as other dietary plant polyphenols, can play an important role in the prevention of pathological conditions associated with inflammation and oxidative stress. This protective role is likely to be due to activities and roles totally independent of their chemical reactivity toward free radicals and their capacity to prevent the oxidation of important intracellular components.
A possible molecular mechanism of these natural compounds is the ability to induce Nrf2 activation, which in turn regulates a number of detoxification enzyme pathways, and in particular, as indicated by our study, HO-1. In this context, natural Nrf2 and HO-1 inducers, such as C3G, might be a potential therapeutic-preventive strategy to protect vascular system against various stressors in several pathological conditions. 
Cyanidin-3-glucoside suppresses TNF--induced cell proliferation through the repression of Nox activator 1 in mouse vascular smooth muscle cells: involvement of the STAT3 signaling
Xiaoqin Luo, Shi Fang, Yunjun Xiao, Fenglin Song, Tangbin Zou, Min Wang, Min Xia, Wenhua Ling Conclusion: These data suggest that C3G exerts its anti-proliferative effects on TNF-ɑinduced vascular smooth muscle cells proliferation through inhibiting signal transducer and activator of transcription 3 activation by attenuating NoxA1-derived reactive oxygen species Funding: This study was supported by grants from the Key Project of National Natural Science Foundation of China (30730079). All authors read and approved the final manuscript.
Published: Molecular and Cellular Biochemistry DOI 10.1007/s11010-011-1144-3 Springer; USA, 2011. ___________________________________________________________________________ Conclusion: C C-3-G treatment induced, in a dose-and time-dependent manner, melanoma cell differentiation characterized by a strong increase in dendrite outgrowth accompanied with a remodeling of the microtubular network, a dramatic increase of focal adhesion and an increased expression of "brain specific" cytoskeletal components such as NF-160 and NF-200 neurofilament proteins. C-3-G treatment also induced increase of cAMP levels and upregulation of tyrosinase expression and activity resulting in an enhanced melanin synthesis and melanosome maturation.
Differentiation of human melanoma cells induced by cyanidin-3-O-βglucopyranoside
Up-regulation of the melanoma differentiation antigen Melan-A/MART-1 in treated cells respect to the untreated control was also recorded. Data obtained provide evidence that a single treatment with C-3-G is able to revert the human melanoma cells from the proliferating to the differentiated state.
We conclude that C-3-G is a very promising molecule to include in the strategies for treatment of melanoma; also because of its nutritional relevance.onclusion: 
Summary of some acknowledged international nutrition-and medicine journals in which clinical studies on Medox® and its two main anthocyanin molecules C 3G and D 3G have been published:
 Multiple studies on the effects of Medox on resting heart rate and blood pressure (in vivo pilot, rat study, placebo controlled), Ullevål University Hospital, Oslo.
Conclusions:
Medox® lowered resting heart rate and blood pressure. ___________________________________________________________________________ . Study on the effect of Medox® single anthocyanin molecules C 3G/D 3G on resting heart rate and blood pressure (placebo controlled rat study), Ullevål University Hospital, Oslo. 
Conclusions
